key: cord-0763241-w3wqfanc authors: Ren, Xiangying; Ren, Xiangge; Lou, Jiaao; Wang, Yongbo; Huang, Qiao; Shi, Yuexian; Deng, Yuqing; Li, Xiaoyan; Lu, Liye; Yan, Siyu; Wang, Yunyun; Luo, Lisha; Zeng, Xiantao; Yao, Xiaomei; Jin, Yinghui title: A systematic review and meta-analysis of discharged COVID-19 patients retesting positive for RT-PCR date: 2021-04-17 journal: EClinicalMedicine DOI: 10.1016/j.eclinm.2021.100839 sha: cf384d7d2fccfbd67fad71692c9323ecad5403bc doc_id: 763241 cord_uid: w3wqfanc BACKGROUND: With the increased number of patients discharged after having COVID-19, more and more studies have reported cases whose retesting was positive (RP) during the convalescent period, which brings a new public health challenge to the world. METHODS: We searched PubMed, Web of Science, The Cochrane Library, CNKI, WanFang and VIP from December 1, 2019 to December 31, 2020. The included studies were assessed using JBI critical appraisal tools and Newcastle-Ottawa Scale. The RP rate of discharge patients was analyzed by a meta-analysis. We adhered to PRISMA reporting guideline. FINDINGS: We have included 117 studies with 2669 RP participants after discharge. The methodological quality of 66 case reports were low to high, 42 case series and 3 cohort study were moderate to high, 3 case-control studies were moderate and 3 cross-sectional studies were low to moderate. The clinical manifestations of most RP patients were mild or asymptomatic, and CT imaging and laboratory examinations were usually normal. The existing risk factors suggest that more attention should be paid to sever patients, elderly patients, and patients with co-morbidities. The summary RP rate was 12·2% (95% CI 10·6–13·7) with high heterogeneity (I(2) = 85%). INTERPRETATION: To date, the causes and risk factors of RP result in discharged patients are not fully understood. High-quality etiological and clinical studies are needed to investigate these issues to further help us to make strategies to control and prevent its occurrence. Since the outbreak of COVID-19 in December 2019, the pandemic has spread to 235 countries, areas or territories of the world [1] . The International Committee on Taxonomy of Viruses (ICTV) has named the organism SARS-COV-2 [2] , and the World Health Organization (WHO) has named the disease Coronavirus Pneumonia 2019 (COVID- 19) . As of December 31, 2020, there has been a total of 80,733,033 confirmed cases worldwide, including 1,783,619 deaths [1] . There are various detection methods for coronavirus, and RT-PCR (real-time reverse transcriptases-polymerase chain reaction) test is the one most used [3, 4] . As more and more patients have been cured and discharged from hospitals, the RT-PCR results of some patients have been reported as turning positive again during the convalescent period. The Lan et al. paper [5] was the first to report four cases of discharged patients retesting positive (RP) by RT-PCR test during convalescence, which has aroused worldwide attention. More studies since have reported similar incidents. One of the largest case series of RP patients for COVID-19 is from Italy, which reported 976 RP patients out of 7127 discharged patients, with a RP rate of 13¢7% [6] . The presence of the RP patient has raised public questions regarding current discharge standards. Are discharge standards too lax? Why do some COVID-19 patients test positive again after they leave the hospital? Is it due to re-infection or relapse? Are the RP patients contagious? All of these issues may exacerbate public panic about COVID-19: it may affect community management of the discharged populations, and pose new potential risks to social and public health. Other reviews on a similar topic have mainly reported on the clinical manifestations of RP patients, sample types of nucleic acid test, and the potential causes of RP [7, 8] . Knowledge about the RP patients is still inadequate and limited. Thus, the purposes of this systematic review and meta-analysis are to comprehensively analyze the COVID-19 patients with RP RT-PCR result after discharged through the inclusion of extensive relevant studies; focus on the clinical characteristics, the possible causes and risk factors. This review was performed and reported in accordance with Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) [9] . An extensive search strategy (appendix p 2) was designed to retrieve all relevant articles published from December 1, 2019 to December 31, 2020, by using six databases: PubMed, Web of Science, The Cochrane Library, CNKI, WanFang and VIP. We applied no restrictions for language of publications. Studies were selected for further consideration through screening of titles, abstracts, and methods for relevance based on the selection criteria after excluding duplications. Three independent researchers (Xiangying Ren, Xiangge Ren and Jiaao Lou) screened retrieved articles and two of them reviewed each article. The same investigators independently assessed full texts of records deemed eligible for inclusion. Any discrepancies were resolved by discussion with other co-authors. Studies were selected based on the following inclusion criteria: (1) Studies about discharged patients with confirmed SARS-CoV-2 infection whose RT-PCR test results were re-positive at any time after discharge; (2) Reported outcomes of interest included description of clinical symptoms, relevant examination results of the RP patients such as, sample types of nucleic acid test, IgG/IgM antibodies, CT imaging, contact tracing, infection ability, treatment, psychological status, prognosis, virology, risk factors of RP; (3) Original research with any type of study designs. Exclusion criteria were: (1) Patients with other serotypes of severe acute respiratory syndrome coronavirus or Middle East respiratory syndrome coronavirus infection; (2) The full texts of studies were not available. Two independent reviewers (Xiangying Ren, Xiangge Ren) extracted data from each eligible study and then proceeded to cross check the results. Disagreements between reviewers regarding extracted data were resolved through discussion and consensus of the third reviewer (Jiaao Lou). The following information was extracted: first author name, date of publication, country, type of study (case report, case series, cohort study, cross-sectional study, case control study), age and sex of the RP patients, the proportion of RP patients in discharged patients, sample type of RT-PCR test, time from discharge to first RP by RT-PCR, serological tests and the CT imaging results of the RP patients. Included articles were independently assessed for quality by three reviewers (Yuqing Deng, Xiaoyan Li and Yuexian Shi) using criteria based on the standard principles of quality assessment. The methodological quality of the included case reports, case series, cross-sectional and case control studies was assessed based on JBI critical appraisal tools [10] . The quality of each checklist item was graded as Yes, No, Unclear or Not applicable. The methodological quality for the cohort studies were assessed based on Newcastle-Ottawa Scale [11] . The three reviewers then shared the quality assessment checklist results and obtained consensus through discussion. If no clinical heterogeneity was considered, we performed a metaanalysis using a random-effects model for the RP rate of discharged patients among studies where the sample size of discharged patients exceeded 30 based on the Central Limit Theorem [12] . I 2 statistic was used to estimate the statistical heterogeneity among the pooled studies [13] . We conducted a cumulative meta-analysis to analyze whether the results tended to be stable with the increase of sample size. We also did sensitivity analyses and then carried out effect-size combination [14] , so as to test the reliability of the results. Finally, we explored the risk of publication bias using the Egger tests [14] . Statistical analyses were executed with the statistical package RStudio. We assumed that different gender, age, disease severity and comorbidities might have an impact on patients who were RP. Therefore, the subgroup analyses were performed by these four factors. Gender (female or male) and age (< 60 years or 60 years) were divided in two groups, respectively. The severity of disease was divided into four types: (1) Mild Type, defined as that the clinical Evidence before this study We searched PubMed, Web of Science, The Cochrane Library, CNKI, WanFang and VIP from December 1, 2019 to December 31, 2020. Among the 3818 references, 117 articles met our preplanned study selection criteria. We also found six systematic reviews and/or meta-analyses. The existing systematic reviews reported on the characteristics, potential reasons, infectivity, treatment and outcome of discharged patients RP for RT-PCR. However, none of them were comprehensive in terms of literature search. The three meta-analysis papers, including 17, 14 and 9 cases respectively, reported estimates of 12%, 329% and 15%, respectively for the RP rate of discharged patients. Through a rigorous and comprehensive systematic review, we not only reported the characteristics of RP patients (such as clinical manifestations, serological tests and virology), pooled the RP rate, performed the subgroup analysis of gender, but also summarized and analyzed the risk factors of RP patients, and the possible causes of RP results. We hope that the results of the current systematic review and meta-analysis will promote the implementation of appropriate discharge standards and management measures, so as to improve people's understanding, diagnosis and proper management of RP patients. We suggested that discharged patients should still use personal protection to reduce the possibility of re-infection or transmission. symptoms were mild with no pneumonia manifestations found in imaging. (2) Moderate Type, patients had symptoms such as fever and respiratory tract symptoms with pneumonia manifestations seen in imaging. (3) Severe Type, patients who met any of the following criteria: respiratory rate 30 breaths/min; oxygen saturations 93% in resting state; arterial partial pressure of oxygen (PaO 2 )/oxygen concentration (FiO 2 ) 300 mmHg. Patients with > 50% lesion progression within 24 to 48 h in lung imaging should be treated as severe cases. (4) Critical Type, meeting any of the following criteria: occurrence of respiratory failure requiring mechanical ventilation; presence of shock; other organ failure that requires monitoring and treatment in the ICU [15] . And co-morbidities were classified into "yes" or "no" categories. The funder of the study had no role in data collection, data analysis, or data interpretation. The corresponding authors had full access to all the data in the study and had final responsibility for the decision to submit for publication. A total of 3818 records were identified in the initial literature search. After removing 916 duplicates, 2902 articles were screened by titles and abstracts, and 2742 articles were excluded. One hundred and sixty studies were reviewed from the full texts and finally 117 articles met the inclusion criteria and were analyzed in the systematic review and meta-analysis (Fig. 1 Overall, the methodological quality of 66 case reports (appendix pp 3À51) were low to high, 42 case series (appendix pp 51À88) were moderate to high and 3 case-control studies (appendix pp 91À93) were moderate. Most studies reported the demographic information and clinical symptoms of patients in detail, and all studies utilized WHO endorsed diagnostic methods. Most studies were conducted in only one hospital and usually restricted to limited geographic areas, and their representativeness was very limited. The methodological quality of three cross-sectional studies were low to moderate (appendix pp 88À91). In the cross-sectional study, 2 of 3 studies did not have clear exposure factors. The methodological quality of two of the three cohort studies were moderate, while the other was high (appendix pp 94À96). Neither cohort study mentioned whether they controlled for confounding factors. In the included studies, the total sample size was 19,795 and 2669 RP patients were reported. Most RP patients' clinical manifestations, laboratory tests and CT imaging showed only mild abnormalities or were normal, and they had no or mild symptoms, such as cough, fever, and fatigue, but a few RP patients died because of co-morbidities. Nineteen studies (n = 101) [16,18,22À25,32,35,36, 49À51,59,73,76,97,104,107,115] showed that discharged patients had no symptoms when the nucleic acid test was positive. Among 55 studies, 1054 RP patients had symptoms, cough (19¢82%) [20,26,29À31,34,38,42,44,49,52,60,62,63,66,67,69,71,74,78,81, 83À85,88,89,91,94,95,98,101,103,106,108,110,119,121,125,127, 130] and fever (14¢99%) [20,28,29,41,44,46,49,52,67,78,82À85,95,102, 103,106,119,130] were the main symptoms, followed by fatigue (6¢26%) [30, 31, 49, 61, 64, 66, 81, 82, 84, 85, 88, 95, 103, 106, 110, 130] , dyspnea (3¢60%) [30, 40, 44, 66, 82, 85, 89, 95, 108, 110, 119] , chest pain and stuffiness (3¢51%) [20, 34, 40, 42, 57, 61, 80, 83, 85, 89, 91, 95, 103, 106, 109, 121, 130] , myalgia (2¢94%) [67, 78, 83, 85, 88, 110, 119, 130] , sore throat (2¢37%) [42, 49, 80, 81, 84, 85, 113, 119, 121, 130] , headache (1¢68%) [20, 26, 84, 85, 113, 119, 130] , diarrhea (1¢42%) [20, 30, 40, 42, 81, 84, 85, 106, 110, 119, 130] , sputum production (1¢21%) [81, 84, 127] and only a few patients had inappetence (0¢75%) [52, 66, 81] , shortness of breath (0¢75%) [20, 81, 84, 130] , nasal congestion (0¢28%) [85, 130] , chill (0¢27%) [63, 119] , nausea (0¢18%) [88, 130] , confusion (0¢18%) [44, 85] , itchy throat (0¢18%) [41, 42] , weakness(0¢18%) [60, 71] , arthralgia (0¢09%) [26] , vomiting (0¢09%) [119] and expectoration (0¢09%) [119] . Almost all of the patients underwent nasopharyngeal swabs during the convalescent period, and according to regional and hospital's requirements, a combination of nasopharyngeal swabs, fecal and sputum testing was used in 7 studies (n = 101) [27, 34, 35, 45, 74, 81, 84] . In these samples, as long as one sample was positive, regardless of whether the patient had clinical symptoms or CT imaging, the patients were defined as RP patients and were re-admitted to hospital. The anal swab positivity rate for SARS-CoV-2 RNA in discharged patients was 14¢3% (6/42). In the positive group, 40% of the patients (2/5) had a positive stool occult blood test (OBT), but none had diarrhea. The median duration of fever and major symptoms (except fever) in the positive patients was shorter than that of the negative patients. The incidence of asymptomatic cases in the positive group (33¢3%) was also higher than that of the negative group (5¢6%) Wu et al. [70] China Case report 1 All indicators of two patients' re-examination were normal, and they were released from isolation after recovery. They were cured without additional treatment, with the appearance of antibodies and the recovery of immune functions Wu et al. [ The incidence of re-positive virus detection in patients who recovered from COVID-19 during quarantine was 6¢2% Liao et al. [116] China Case series À À À 10/28 2À15 d positive À À À A total of 10 patients tested SARS-CoV-2 positive at least once and 9 had more than two SARS-CoV-2 positive tests within 30 days after being discharged from the hospital An et al. [109] China Fifteen studies reported that both IgG and IgM were positive in RP patients [24, 28, 32, 40, 46, 47, 51, 59, 60, 66, 69, 70, 85, 109, 117] . However, one RP patients was reported as testing negative for antibodies in one study [25] . In most patients, CT imaging had improved compared with the first admission, and pulmonary lesions were fully absorbed in some patients. However, among 656 RP patients having abnormalities in CT imaging, there were bilateral pulmonary infiltration (15¢2%) [20, 28, 29, 83, 84, 116, 117] , consolidation of lung tissue (7¢8%) [77, 79, 83, 86, 117] , ground-glass opacity (GGO) (7¢7%) [20, 44, 67, 78, 84, 86, 89, 104, 119] , pulmonary plaques (3¢5%) [34, 80, 84] , fibrinous exudation on the surface of the lung (2¢7%) [34, 104, 117] , pneumonia (1¢4%) [20, 29, 104, 116] , the light density shadow of the lung (0¢6%) [51, 77, 84] , interstitial abnormalities (0¢4%) [84] , bilateral proximal lobar pulmonary embolism (0¢4%) [29, 40] , segmental and sub-segmental signs of arterial micro-embolism (0¢3%) [40] , and pleural effusion (0¢15%) [65] . Fourteen studies reported that RP patients had contacted with others before they were RP for RT-PCR [5, 18, 20, 30, 37, 42, 47, 52, 59, 67, 84, 93, 98, 110] . In these studies, only one study reported one RP patient whose family members developed respiratory symptoms and tested positive for SARS-COV-2 nucleic acid [67] . Other studies reported that these contact persons were neither diagnosed with COVID-19 nor had any respiratory symptoms. Most of the reports did not mention whether the discharged patients continued to take antiviral drugs during the convalescent period. Two studies mentioned that the discharged patients did not take any drugs during the convalescent period [47, 101] . Fu et al. reported that three RP patients had received traditional Chinese medicine treatment during isolation after discharge [23] . Patrocínio de Jesus et al. described a patient who received prednisolone after discharge [67] . He et al. reported that the patients received various interventions during convalescent period, including Baduanjin exercise, Tongzhi Granule, Moxibustion with acupoint application [123] . Most of the studies did not mention the treatment management for the patients who were readmitted. In the ones that reported treatment strategies, most RP patients took chloroquine phosphate, Lopinavir, Arbidol Hydrochloride or Interferon-2B [21, 25, 37, 51, 97] . Some patients were also treated with immune-related drugs such as thymic pentapeptide [97] or immunoglobulin [51] . Traditional Chinese medicines were also used for treatment during the second hospitalization [53, 77, 109, 116, 124] . Only two studies reported the psychological status of patients after re-hospitalization. Mei et al. reported an 80-years-old RP patient with suicidal tendency during re-hospitalization [95] . Peng et al. found nonorganic insomnia and increased anxiety in two RP patients [41] . Eight studies reported prognosis of RP patients, and four of which reported that the RP patients (n = 4) were in good physical condition [25, 26, 40, 59] . Raviol et al. reported that an 81-year-old patient who had been readmitted to hospital with dyspnea, fever, and unconsciousness, suffered progressive symptoms leading to death [44] . Gousseff [29] . Five studies with total 16 RP patients reported that their Ct (Cycle threshold) values was higher than those at their first hospitalization, suggesting a decrease in viral load [43, 47, 60, 63, 98] . Liu et al. reported that 3 of 4 RP patient's viral load deceased with the length of discharge time, but one patient had risen [39] . Song et al. reported that the Ct values fluctuated in all the four patients [69] . Gao et al. reported that the patient who tested repeatedly positive after discharge had higher viral loads at the first and third admission than during the middle term of the disease [24] . Hu et al. found no difference in viral load in eight RP patients between the first positive and repeated positive tests [61] . Lu et al. reported that they obtained zero full-length SARS-CoV-2 genomes by sequencing 94 samples from 54 patients and the corresponding sequencing coverage ranged from 0¢00% to 75¢48% [125] . Goldman et al. reported sequenced viruses from two distinct episodes of symptomatic COVID-19 separated by 140 days in a single patient, and found the patient was re-infected with a new strain [60] . Lee et al. reported that they obtained the complete genetic sequence of the virus from one female patient among 6 RP patients, suggesting that there was a re-infection of SARS-CoV-2 with a subtype that was different from that of the primary strain [63] . Three studies reported virus culture from 40 nasopharyngeal or fecal swab samples from RP patients. Two studies failed to produce live virus [122, 125] and only the third study, Gousseff et al., reported that one of two patients had a positive virus culture and this was accompanied by typical SARS-COV-2 cytopathic disease [85] . Two studies found through viral gene sequencing that the positive nucleic acid tests were due to re-infection in 2 patients [60, 63] . Based on the results of included studies [83, 98, 99, 107, 110, 112, 115, 117, 118, 121, 129] , we found that patients classified with a severe first episode [112] , aged 60 years and above [98] , and co-morbidities were more likely to be RP after discharge [99, 121] , especially those having hypertension or chronic respiratory diseases [121] . When compared with the patients without RP results, the RP patients had a higher level of fever [107, 129] , a higher proportion with symptoms like diarrhea [118] , sore throat, and rhinitis [115] , and a higher level of some laboratory indices such as serum IL-6 [83] , ALT, AST [110] , erythrocyte sedimentation rate, D-dimer [129] , lymphocyte ratio [121] than those at the first hospitalization. However, neutrophil counts were comparatively lower [107] . According to the results of CT scans, the proportion of patients with lung consolidation or bilateral pulmonary infiltration were higher in the RP patients [83] . Moreover, they may have had a longer hospital stay [99, 129] , and higher proportion receiving antibiotics and/or glucocorticoid treatment that those when they were first infected [99] . In addition to the above results, Deng et al. reported that in pediatric patients infected with SARS-CoV-2, family cluster infection, higher white blood cell counts, and longer plasma prothrombin time are the early risk factors of RP [117] . Forty-three studies with a sample size of more than 30 and with a total of 17,774 discharged patients were included in the meta-analysis according to our pre-planned rule. Among them, 39 studies were conducted in China, 3 in Italy, and 1 in Brunei Darussalam. The range of discharged patients for every study was from 34 to 7127, the RP rates ranged from 2¢38% [20] to 36¢8% [117] . The pooled RP rate was 12¢2% (95% CI 10¢6À13¢7) with high heterogeneity (I 2 = 85%) (Fig. 2) . Cumulative meta-analysis showed that the point estimation value was gradually stable with the increase of sample size, and the confidence interval was gradually narrowed, indicating that the accuracy of results improved with larger samples (appendix p 97). After removing one study from the analysis each time, the results of 42 sensitivity analyses showed good consistency with the range of RP rate from 12¢0% to 12¢6% (appendix p 98). Meanwhile, Egger's test showed there was publication bias among the studies (P = 0¢0027). Twelve studies [20, 83, 87, 90, 91, 99, 100, 103, 104 ,106À108] also reported RP rates for males and females, respectively. The results showed that RP rate of females was 12¢3% (95% CI 8¢9À16¢2) and males was 12¢1% (95% CI 8¢1À16¢8) with high heterogeneity (I 2 = 75%) (appendix p 99). There are no available data for us to calculate the results of subgroup analyses for age, disease severity and co-morbidities. In this systematic review and meta-analysis, the clinical manifestations of the RP patients were usually normal or mild, and the CT imaging and laboratory examination were mostly normal. However, the RP patients accounted for approximately 12% of the discharge patients, which is enough to arouse our concern. Are they not cured or have they been re-infected? Are the RP patients infectious or not, and what are the risk factors causing them to retest positive? All these problems need to be explored in depth at this time. The chief reasons for patient becoming RP are potentially as follows: 1. The results of RT-PCR may be a false negative at discharge. RT-PCR results are often used as an indicator of patients' diagnosis, discharge and isolation, but the sensitivity of RT-PCR detection is affected by many factors, such as sample type, sample collection, sample transportation and instability of test kits or variance of technicians in different labs. At present, nasopharyngeal swab samples are commonly used for RT-PCR test. The operation of collecting samples is highly dependent on the operator's experience and it is possible that the location of the samples is not accurate. Even if the operation is correct, the target virus might not be collected [16] , which might lead to the possibility of false negative test results at discharge. 2. The emergence of RP results may due to incomplete elimination of the virus. The clearance of novel coronavirus from the body may take a long time [131À133], even after a respiratory specimen had tested negative for a coronavirus, stool samples have tested positive for the virus for up to five weeks [132] . Two studies reported that patients still shed the virus during the convalescent period which was confirmed by samples collected in the isolation room [134, 135] . One study reported that patients discharged from hospital might present with SARS-CoV-2 reactivation [136] . Short duration of immunity that could explain the reactivation of the virus after a period of negative viral testing. We have not been able to confirm the exact correlation between the factors such as use of the glucocorticoids, older age, co-morbidities and the RP events at present, but our results show that patients with these characteristics have a relatively high likelihood of RP results. Glucocorticoids are still used in the treatment of COVID-19, although their clinical application has been controversial [137] . Some studies have shown that although glucocorticoids can inhibit lung inflammation, they can also damage the activity of B and T lymphocytes, and may inhibit pathogen clearance and immune response of the body [138, 139] . Immunosenescence in older patients also impairs innate and adaptive immune responses [140, 141] . There seems to be a common denominator among these factors: they all have some degree of influence on the body's immune response. Immune response is the body's response to viral infection. Macrophages, neutrophils and dendritic cells produce a nonspecific innate response that slows the virus' progress and may even prevent the virus from causing symptoms [142] . After this non-specific response, the body will generate an adaptive immune response that specifically binds to the virus, and the adaptive response of this combination may clear the virus from the body [141] . Therefore, we can infer that if the patient's immune response has been suppressed, the process of viral clearance may also be prolonged, and the ability to inhibit virus replication will be relatively weakened. Therefore, the nucleic acid test results may become positive again after discharge. Although nearly 12% of patients still test positive after discharge based on the available evidence, most of these patients were asymptomatic or with mild symptoms, the viral load was low, the virus culture showed no activity, and there were only one report of infection in close contacts, suggesting that the possibility of further virus transmission was low [143] . We should not be panic about RP patients. But recently, some studies have reported that discharged patients may become re-infected with different strains of the virus [144] [145] [146] [147] [148] [149] , which reminds us that re-infection appears to be a possibility in convalescent patients. When confirming the diagnosis of re-infection, it is necessary to identify two different phylogenetic strains [150] . To et al. reported the first case of reinfection with COVID-19, whose result of whole genome analysis showed that different virus strains were identified in each infection event [147] . These rare phenomena suggested that previous exposure to COVID-19 might not guarantee total immunity [148] . Above all, it is still necessary for discharged patients to use personal protection to reduce the possibility of re-infection or transmission. In addition, some RP patients experienced high psychological pressure, leading to organic insomnia and anxiety aggravation, which in turn may lead to the change of their conditions [41] . It is necessary to give sufficient mental health care for these RP patients. Although six systematic reviews and/or meta-analyses have been already published [142,151À155] , none of them were comprehensive in terms of literature search. For example, one systematic review did not report the results of a systematic search, the number of included studies was uncertain [151] . Another one systematic review only described the number of days from discharge to relapse and the symptoms of PR patients, which provided less information [142] . Three meta-analysis included small numbers of cases, including 17 [155] , 14 [154] and 9 [153] cases, respectively. And five of them did not assess the quality assessment [151À155]. We have summarized and analyzed the clinical characteristics of these RP cases, pooled the RP rate, performed the subgroup analysis of gender, focused on the possible causes of RP results, and provided some suggestions for management. However, there are some limitations in this current review. First, most available studies were from China, and were single-center observational studies. Additionally, some study types were unclear. Second, the quality of most articles was not high. Many of studies have design faults, and some problems may exist in the statistical methods. For example, the potential confounding factors were not controlled, which might lead to uncertain estimation. Third, in the meta-analysis section, we did not conduct subgroup analyses for age, disease severity and co-morbidities, because the data of the relevant subgroups could not be completely extracted and merged. In conclusion, most of the RP patients had normal clinical manifestations or only mild symptoms, and laboratory and CT imaging showed improvement compared with those at their first discharge. In the future, more high-quality studies with appropriate sample size calculation are urgently needed to help us understand the etiology and pathological mechanism of being RP, and further help us to make strategies to control and prevent its occurrence. All authors reported grants from Emergency Special Project for COVID-19 of Wuhan Municipal Health Commission, during the conduct of the study. Jin et al. [15, 156] [15, 156] . Ren and Shi reported grants from First Level Funding of the Second Medical Leading Talent Project in Hubei Province, National Key Research and Development Program of China, and Special Project for Emergency of Hubei Province, outside the submitted work [15] . Jin, Zeng and Yao are the first author and corresponding authors, respectively and are members of the steering group, Ren, Huang, Luo, Wang and Shi are authors and are members of the systematic review group in Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: An evidence-based clinical practice guideline (updated version) [15] . Jin, Zeng are first author and corresponding author, respectively and are members of the steering group, Yao, Huang, Luo and Wang are authors and members of the systematic review group in A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version) [156] . Zeng and Jin reported research projects involving infection of healthcare workers during this epidemic, which was supported by Special Project for Emergency of Hubei Province (2020FCA008). Yinghui Jin, Xiaomei Yao and Xiantao Zeng conceived and designed the study. Xiangying Ren, Xiangge Ren and Jiaao Lou were involved in the search process, study selection and data extraction, and wrote the manuscript. Qiao Huang, Yongbo Wang, Siyu Yan, Yunyun Wang, Lisha Luo and Liye Lu were involved in data analysis, study selection and data handling, and commented on drafts of the manuscript. Yuqing Deng, Xiaoyan Li and Yuexian Shi were involved in the quality assessment and commented on the manuscript. Yinghui Jin, Xiaomei Yao and Xiantao Zeng revised the manuscript. All authors reviewed the study findings and approved the final version before submission. Emergency Special Project for COVID-19 of Wuhan Municipal Health Commission (EG20A02). WHO Coronavirus Disease (COVID-19) Dashboard. 2020 The International Committee on Taxonomy of Viruses (ICTV). 2020 Laboratory diagnosis of emerging human coronavirus infections -the state of the art Interpreting diagnostic tests for SARS-CoV-2 Positive RT-PCR test results in patients recovered from COVID-19 Persistent positivity and fluctuations of SARS-CoV-2 RNA in clinically-recovered COVID-19 patients Recurrence of SARS-CoV-2 viral RNA in recovered COVID-19 patients: a narrative review Discharged COVID-19 patients testing positive again for SARS-CoV-2 RNA: a minireview of published studies from China Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement NOS Significance, errors, power, and sample size: the blocking and tackling of statistics Measuring inconsistency in meta-analyses Cochrane handbook for systematic reviews of interventions Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: an evidence-based clinical practice guideline (updated version) The clinical characteristic of eight patients of COVID-19 with positive RT-PCR test after discharge Re-evaluation of retested nucleic acid-positive cases in recovered COVID-19 patients: report from a designated transfer hospital in Chongqing A case presentation for positive SARS-CoV-2 RNA recurrence in a patient with a history of type 2 diabetes that had recovered from severe COVID-19 Serial CT features in discharged COVID-19 patients with positive RT-PCR re-test Prevalence and outcomes of re-positive nucleic acid tests in discharged COVID-19 patients One discharged patient turning positive again for SARS-CoV-2 after isolation Analysis of re-admission of patients with coronavirus disease 2019 after treatment Letter to the Editor: three cases of redetectable positive SARS-CoV-2 RNA in recovered COVID-19 patients with antibodies Absent immune response to SARS-CoV-2 in a 3-month recurrence of coronavirus disease 2019 (COVID-19) case Recurrent positive nucleic acid detection in a recovered COVID-19 patient: a case report and literature review Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review Variability between testing methods for SARS-CoV-2 nucleic acid detection 16 days post-discharge: a case report Progressive CT findings and positive RT-PCR again of recovered and discharged patients with COVID-19 Recurrence or relapse of COVID-19 in older patients: a description of three cases Positive RT-PCR nasopharyngeal swab in patients recovered from COVID-19 disease: when does quarantine really end? The treatment of 2 discharged patients with COVID-19 retested positive for viral nucleic acid SARS-CoV-2 positivity in a discharged COVID-19 patient: a case report Analysis of long time detoxification of 1 patient with COVID-19 A case of a readmitted patient who recovered from COVID-19 in Chengdu Positive result of Sars-Cov-2 in faeces and sputum from discharged patients with COVID-19 in Yiwu Follow-up testing of viral nucleic acid in discharged patients with moderate type of Repeated COVID-19 relapse during post-discharge surveillance with viral shedding lasting for 67 days in a recovered patient infected with SARS-CoV-2 Positive SARS-CoV-2 RNA recurs repeatedly in a case recovered from COVID-19: dynamic results from 108 days of follow-up Detection of SARS-CoV-2 by RT-PCR in anal from patients who have recovered from coronavirus disease 2019 Recurrence of COVID-19 after recovery: a case report from Italy Seven discharged patients turning positive again for SARS-CoV-2 on quantitative RT-PCR Re-positive cases of nucleic acid tests in discharged patients with COVID-19: a follow-up study Analysis of 3 discharged patients with COVID-19 retested positive for viral nucleic acid Reactivation of COVID-19 pneumonia: a report of two cases Anal swab as a potentially optimal specimen for SARS-CoV-2 detection to evaluate hospital discharge of COVID-19 patients Rehospitalization of a recovered coronavirus disease 19 (COVID-19) child with positive nucleic acid detection Recurrent presence of SARS-CoV-2 RNA in a 33-year-old man Post-discharge surveillance and positive virus detection in two medical staff recovered from coronavirus disease 2019 (COVID-19), China Follow-up results of COVID-19 patients after discharge in Chongqing Analysis of discharged coronavirus disease 2019 patients retested positive for viral nucleic acid in Chenzhou City Low humoral immune response and ineffective clearance of SARS-Cov-2 in a COVID-19 patient with CLL during a 69-day follow-up Reactivation of SARS-CoV-2 after recovery Positive rectal swabs in young patients recovered from coronavirus disease 2019 (COVID-19) Detectable SARS-CoV-2 viral RNA in feces of three children during recovery period of COVID-19 pneumonia Analysis of re-positive nucleic acid conversion in patients recovered from COVID-19 in Tianjin A case series of recurrent viral RNA positivity in recovered COVID-19 chinese patients Re-emergence of SARS-CoV2 in a discharged COVID-19 case Recurrent pneumonia in a patient with new coronavirus infection after discharge from hospital for insufficient antibody production: a case report An unusual COVID-19 case with over four months of viral shedding in the presence of low neutralizing antibodies: a case report Reinfection with SARS-CoV-2 and failure of humoral immunity: a case report. medRxiv 2020 the preprint server for health sciences Surveillance and re-positive RNA test in patients recovered from COVID-19 Novel coronavirus repeated positive virus nucleic acid in 2 patients over 60 days Evidence of severe acute respiratory syndrome coronavirus 2 reinfection after recovery from mild coronavirus disease 2019 Implications of two confirmed cases of COVID-19 with positive nucleic acid retests after discharge from hospital Recurrent COVID-19 pneumonia in the course of chemotherapy: consequence of a weakened immune system Investigation of family reappear cases after discharge of a COVIDÀ19 case in Wuhan City Reactivation of SARS-CoV-2 after asymptomatic infection while on high-dose corticosteroids. Case report Analysis of 3 discharged patients with COVID-19 retested positive for viral nucleic acid Dynamics of viral load and anti-SARS-CoV-2 antibodies in patients with positive RT-PCR results after recovery from COVID-19 Recurrence of SARS-CoV-2 nucleic acid positive test in patients with COVID-19: a report of two cases Clinical characteristics and outcomes of discharged COVID-19 patients with reoccurrence of SARS-CoV-2 RNA Follow-up study of long-time positive rt-pcr in stool specimens from asymptomatic children infected with SARS-CoV-2 Diagnosis and treatment process of a case of "Fuyang" after recovery of light COVID-19 and its influencing factors Analysis of positive recurrence of nucleic acid in COVID-19 patients from taiyin Positive SARS-CoV-2 viral RNA test in a COVID-19 patient after cure: one case report Retest positive for SARS-CoV-2 RNA in pregnant women recovered from COVID-19 Case report: recurrence of positive SARS-CoV-2 results in patients recovered from COVID-19 Re-positive nucleic acid detection in COVID-19 patients after discharge from hospital Clinical and imaging findings of discharged patients with SARS-CoV-2 positive anal swab samples: a descriptive study Re-positive nucleic acid detection in one COVID-19 patient after discharge from hospital Characteristics of 30 re-hospitalized patients with re-positive of 2019-nCoV nucleic acid The dilemma of COVID-19 recurrence after clinical recovery Clinical course and risk factors for recurrence of positive SARS-CoV-2 RNA: a retrospective cohort study from Wuhan Positive results for patients with COVID-19 discharged form hospital in Chongqing, China Clinical recurrences of COVID-19 symptoms after recovery: viral relapse, reinfection or inflammatory rebound? Rate of re-positive RT-PCR test among patients recovered from COVID-19 Recurrent positive reverse transcriptase-polymerase chain reaction results for coronavirus disease 2019 in patients discharged from a hospital in China Recurrent PCR positivity after hospital discharge of people with coronavirus disease 2019 (COVID-19) Chest CT study of fifteen COVID-19 patients with positive RT-PCR retest results after discharge Characteristics of discharged coronavirus disease 2019 patients retested positive for viral nucleic acid in Shenzhen city Clinical features of discharged COVID-19 patients with an extended SARS-CoV-2 RNA positive signal in respiratory samples The analysis of re-positive rate of throat swab nucleic acid test in ordinary patients with COVID-19 Chest computed tomography and clinical follow-up of discharged patients with COVID-19 in Wenzhou city Changes in serum virus-specific IgM/IgG antibody in asymptomatic and discharged patients with reoccurring positive COVID-19 nucleic acid test (RPNAT) Assessment of patients who tested positive for COVID-19 after recovery Application value of nasal and oropharyngeal swabs in COVID-19 The treatment and follow-up of 'recurrence' with discharged COVID-19 patients: data from Guizhou, China Probable causes and risk factors for positive SARS-CoV-2 test in recovered patients: evidence from Brunei Darussalam Twelve out of 117 recovered COVID-19 patients retest positive in a single-center study of China Recurrence of positive SARS-CoV-2 viral RNA in recovered COVID-19 patients during medical isolation observation PCR assays turned positive in 25 discharged COVID-19 patients Characteristics of children with reactivation of SARS-CoV-2 infection after hospital discharge Recovery of pneumonia in 27 discharged COVID-19 patients with positive virus detection Incidence, clinical course and risk factor for recurrent PCR positivity in discharged COVID-19 patients in Guangzhou, China: a prospective cohort study Characteristics of 11 discharged patients with COVID-19 retested positive for viral nucleic acid Clinical features of COVID-19 convalescent patients with re-positive nucleic acid detection Factors influencing the outcome of 34 patients with COVIDp19 The issue of recurrently positive patients who recovered from covid-19 according to the current discharge criteria: investigation of patients from multiple medical institutions in Wuhan Clinical characteristics of recovered COVID-19 patients with re-detectable positive RNA test Epidemiological and clinical findings of short-term recurrence of severe acute respiratory syndrome coronavirus 2 ribonucleic acid polymerase chain reaction positivity in 1282 discharged coronavirus disease 2019 cases: a multicenter, retrospective, observational study The role of albumin/globulin ratio in discharged covid-19 patients with re-positive nucleic acid detection Clinical characteristics of "re-positive" discharged COVID-19 pneumonia patients in Wuhan Clinical characteristics of discharged COVID-19 patients with reappeared positive nucleic acid test Kinetics of SARS-CoV-2 positivity of infected and recovered patients from a single center Predictive factors for a new positive nasopharyngeal swab among patients recovered from COVID-19 Longitudinal changes on clinical features in 28 children with COVID-19 in Shenzhen Risk factors for redetectable positivity in recovered COVID-19 children Positive RT-PCR tests among discharged COVID-19 patients in Shenzhen Positive virus detection in patients who recovered from COVID-19 during quarantine period between discharge and home: a two-center experience in Wuhan, China Clinical characteristics and "Fuyang" results of 41 COVID-19 patients Clinical characteristics of re-positive COVID-19 patients in Huangshi, China: a retrospective cohort study Persistent viral presence determines the clinical course of the disease in COVID-19 Positive RT-PCR Test results in 420 patients recovered from COVID-19 in Wuhan: an observational study Clinical features and outcomes of discharged coronavirus disease 2019 patients: a prospective cohort study Clinical, immunological and virological characterization of COVID-19 patients that test re-positive for SARS-CoV-2 by RT-PCR The analysis of re-positive rate of throat swab and feaces nucleic acid test in ordinary patients with COVID-19 Coronavirus disease 2019 test results after clinical recovery and hospital discharge among patients in China Can elevated concentrations of ALT and AST predict the risk of 'recurrence' of COVID-19? Characteristics and risk factors analysis for "RNA Re-tested positive" in patients recovering from COVID-19 Analysis of positive recurrence of nucleic acid in COVID-19 patients during isolation observation period after discharge Prolonged persistence of SARS-CoV-2 RNA in body fluids Prolonged presence of SARS-CoV-2 viral RNA in faecal samples Duration of viral shedding of discharged patients with severe COVID-19 SARS-CoV-2 presented in the air of an intensive care unit (ICU) SARS-CoV-2 environmental contamination associated with persistently infected COVID-19 patients Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation A critical evaluation of glucocorticoids in the management of severe COVID-19 Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury Controversial treatments: an updated understanding of the coronavirus disease 2019 Nasopharyngeal shedding of severe acute respiratory syndrome-associated coronavirus is associated with genetic polymorphisms Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study The Possibility and cause of relapse after previously recovering from COVID-19: a systematic review Virological assessment of hospitalized patients with COVID-2019 Asymptomatic reinfection in two healthcare workers from India with genetically distinct SARS-CoV-2 Symptomatic SARS-CoV-2 reinfection by a phylogenetically distinct strain A case of early Re-infection with SARS-CoV-2 COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing Genomic evidence for reinfection with SARS-CoV-2: a case study COVID-19 re-infection by a phylogenetically distinct SARS-CoV-2 variant, first 1 confirmed event in South America Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity A systematic review of re-detectable positive virus nucleic acid among COVID-19 patients in recovery phase Is recurrence possible in coronavirus disease 2019 (COVID-19)? Case series and systematic review of literature Systematic review and meta-analysis of factors associated with re-positive viral RNA after recovery from COVID-19 Recurrent positive SARS-CoV-2 RNA tests in recovered and discharged patients SARS-CoV-2 recurrent RNA positivity after recovering from coronavirus disease 2019 (COVID-19): a metaanalysis A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version) We thank Jean Glover from Tianjin Golden Framework Consulting Company for English editing. The data used in this study were gathered from publicly available studies and available from the corresponding authors upon reasonable request. Supplementary material associated with this article can be found in the online version at doi:10.1016/j.eclinm.2021.100839.